GreenLight Biosciences Holdings
GRNA · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $32 | $68 | $98 | $44 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $10 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $3 | $11 | $10 |
| Total Curr. Assets | $38 | $71 | $109 | $64 |
| Property Plant & Equip (Net) | $73 | $74 | $39 | $32 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $3 | $3 | $3 |
| Total NC Assets | $76 | $77 | $42 | $35 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $114 | $149 | $151 | $99 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $3 | $4 |
| Short-Term Debt | $18 | $17 | $13 | $11 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $4 | $7 | $9 |
| Other Curr. Liab. | $12 | $14 | $9 | $31 |
| Total Curr. Liab. | $31 | $36 | $32 | $55 |
| LT Debt | $60 | $64 | $17 | $20 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $18 | $10 |
| Total NC Liab. | $61 | $65 | $35 | $30 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $92 | $101 | $67 | $85 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $151 | $99 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$449 | -$421 | -$382 | -$344 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $471 | $469 | $315 | $259 |
| Total Equity | $22 | $48 | $84 | $14 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $114 | $149 | $151 | $99 |
| Net Debt | $45 | $12 | -$69 | -$13 |